Pamela McGarrah, MD
Otolaryngology · Sheffield, ALNPI 1407957129
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,353 of the $3,814 with a category attached, or 87.9%. Medtronic accounts for 65.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,589 and has fallen 94.9% since, to $81 in 2025.
Across 33 payments — averaging $115.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Medical Device Business Services, Inc.$1K
- Intersect ENT, Inc.$85
- Stryker$42
- Galt Pharmaceuticals, LLC$29
- Kerecis Limited$28
- plus $58 from 3 others
What the payments were for
- Travel & lodging$3,35388%
- Food & beverage$45712%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $2,477 |
| Medical Device Business Services, Inc. | 7 | $1,095 |
| Intersect ENT, Inc. | 3 | $85 |
| Stryker | 3 | $42 |
| Galt Pharmaceuticals, LLC | 1 | $29 |
| Kerecis Limited | 1 | $28 |
| Sanofi | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| GSK | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUADCUT$1,350
- STEALTHSTATION S8 PLATFORM$558
- PROPEL$290
How this compares
$3,814 in reported general payments places this provider in the 75th percentile of 155 otolaryngology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 17 | $2,131 |
| Cefdinir | 38 | $884 |
| Montelukast Sodium | 67 | $494 |
| Ipratropium Bromide | 12 | $363 |
| Fluticasone Propionate | 31 | $333 |
| Mupirocin | 43 | $327 |
| Nystatin | 23 | $241 |
| Gentamicin Sulfate | 11 | $196 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $183 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 17 | $177 |
| Levocetirizine Dihydrochloride | 12 | $126 |
| Levofloxacin | 17 | $111 |
| Ondansetron OdtOndansetron | 12 | $102 |
| Prednisone | 29 | $47 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Sheffield
- Francis LongSheffield$7K
- John DavisHoover$251K
- William McFeelyHuntsville$70K
- Michael SillersBirmingham$53K
- Justin TurnerBirmingham$34K
- Bradford WoodworthBirmingham$27K
- Patrick OwensBirmingham$26K
- Kirk WithrowBirmingham$22K
- Do-Yeon ChoBirmingham$19K
- William BlytheOpelika$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.